Single- and multiple-dose pharmacokinetics and total removal of colistin in a patient with acute kidney injury undergoing extended daily dialysis

J Antimicrob Chemother. 2014 Jul;69(7):2008-10. doi: 10.1093/jac/dku075. Epub 2014 Mar 20.

Authors

Ann-Kathrin Strunk¹, Julius J Schmidt¹, Eva Baroke², Stefanie M Bode-Böger³, Jens Martens-Lobenhoffer³, Tobias Welte², Jan T Kielstein⁴

Affiliations

¹ Department of Nephrology and Hypertension, Medical School Hannover, Hannover, Germany.
² Department of Pulmonary Medicine, Medical School Hannover, Hannover, Germany.
³ Institute of Clinical Pharmacology, Otto von-Guericke-University of Magdeburg, Magdeburg, Germany.
⁴ Department of Nephrology and Hypertension, Medical School Hannover, Hannover, Germany kielstein@yahoo.com.

PMID: 24651826
DOI: 10.1093/jac/dku075

No abstract available

Keywords: CMS; PK; colistin methanesulfonate; renal replacement therapy.

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Acute Kidney Injury / therapy*
Adult
Anti-Bacterial Agents / administration & dosage*
Anti-Bacterial Agents / pharmacokinetics*
Colistin / administration & dosage*
Colistin / pharmacokinetics*
Humans
Plasma / chemistry
Renal Dialysis / methods*

Substances

Anti-Bacterial Agents
Colistin